Insider Transactions Reported by 32 Insiders of Dianthus Therapeutics, Inc. /DE/

Symbol
DNTH on Nasdaq
Location
New York, NY

Insiders trading volume in the past year

Dianthus Therapeutics, Inc. /DE/ executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Lei Meng Director $54,608,811 22 Jan 2024
Fairmount Funds Management LLC Director $42,395,456 27 Sep 2024
Third Rock Ventures IV, L.P. 10%+ Owner $36,698,448 07 Feb 2023
Leon O. Moulder Jr. Director $17,240,940 23 May 2024
JASON GARDNER Title: President and Chief Executive Officer, Director $11,339,448 30 Nov 2022
Kristen Stants Chief People Officer $243,168 30 Nov 2022
Thomas W. Beetham Title: Chief Legal Officer and Secretary $238,764 30 Nov 2022
Caren Deardorf Chief Commercial Officer $237,144 30 Nov 2022
Stephen F. Mahoney Title: Chief Financial and Operating Officer $207,168 30 Nov 2022
Simrat Randhawa EVP, Head of R&D $152,560 -$7,379,887 -98% 03 Feb 2026
Alexis Borisy Director $49,200 26 Aug 2021
Ryan Savitz Evp, Cfo & Cbo $0 -$1,603,600 -100% 03 Feb 2026
Marino Garcia CEO AND PRESIDENT, Director 03 Feb 2026
Steven J. Romano Director 22 May 2025
SUJAY KANGO Director 04 Mar 2025
Simon Read Director 22 May 2025
Alison Frances Lawton Director 22 May 2025
Jonathan Violin Director 22 May 2025
Anne McGeorge Director 22 May 2025
Paula Soteropoulos Director 22 May 2025
Adam M. Veness SVP, General Counsel and Sec. 03 Feb 2026
EDWARD CARR Chief Accounting Officer 03 Feb 2026
Bruce Booth Director 28 Jun 2022
MICHAEL W. BONNEY Director 01 Jun 2021
David Scadden Director 28 Jun 2022
MICHAEL VASCONCELLES Director 15 Aug 2022
Daniel Thomas O. Director 28 Jun 2022
Jeffrey Humphrey Chief Medical Officer 01 Aug 2022
Jeffrey W. Albers Director 28 Jun 2022
David Wayne Nichols Chief Technical Officer 01 Aug 2022
Lisa Olson Title: Head of Research and Chief Scientific Officer Exhibit 24.1: Power of Attorney 01 Aug 2022
AMY L. RONNEBERG Director 28 Jun 2022

Recent Insider Transactions by Companies or Individuals for Dianthus Therapeutics, Inc. /DE/

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.